Clinical Trial Update: The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether adding Yttrium-90 radiotherapy to gemcitabine, cisplatin, and durvalumab improves tumor shrinkage and disease control in i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Durvalumab (durvalumab)
• Gemcitabine (Gemcitabine)
• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Inova Health Care Services | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING